Response to ''Inguinal Node Status by Ultrasound in Vulva Cancer'' (Abang Mohammed et al. Gynecol Oncol 2000;77:93-6) - To the Editor

By Moskovic E.  

Gynecologic Oncology, Vol. 81, Iss. 1, 2001-04 ,pp. : 123-123

Elsevier

Access to resources Recommend Favorite

Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized, phase II, placebo-controlled trial. Carducci MA, Padley RJ, Breul J, Vogelzang NJ, Zonnenberg BA, Daliani DD, Schulman CC, Nabulsi AA, Humerickhouse RA, Weinberg MA, Schmitt JL, Nelson JB, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD - J Clin Oncol 2003;21:679-689

By Trump D.L.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 5, 2003-09 ,pp. : 410-411

Elsevier

Access to resources Recommend Favorite

Quality-of-care indicators for early-stage prostate cancer - Spencer BA, Steinberg M, Malin J, Adams J, Litwin MS, RAND Health Science Program, Sanata Monica, CA. J Clin Oncol 2003;21:1928-1936

By Carroll P.R.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 6, 2003-11 ,pp. : 485-485

Elsevier

Access to resources Recommend Favorite

Editorial [Hot topic: Prostate Cancer Therapy (Guest Editors: N. Sharifi and J.B. Aragon-Ching)]

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 10, 2009-12 ,pp. : 1039-1039

Bentham Science Publishers

Access to resources Recommend Favorite

Critical review of complementary therapies for prostate cancer - Wilkinson S, Chodak GW, Midwest Prostate and Urology Health Center, Weiss Memorial Hospital, Chicago, IL. J Clin Oncol 2003;21:2199-2210

By Chatta G.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 6, 2003-11 ,pp. : 491-491

Elsevier

Access to resources Recommend Favorite